-transparent.png){kind=logo}
One hundred and sixty-four patients with Graves' disease were treated with low-dose radioiodine (2 mCi), with a mean follow up of 4 1/2 years. At this time 74 (45%) were euthyroid having had a single dose, with a total of 131 (80%) being controlled with one or more doses. Three (2%) were still toxic but their mean follow up was only 3 years. Thirty (18%) were rendered hypothyroid, two-thirds of these after a single dose of 2 mCi 131I. The one-year incidence of hypothyroidism was 6%, with an incidence at 6 years of 20%. Previous surgery, medical treatment and thyroid antibody status appeared to have no influence on the outcome.
Related Publications
C P Lowdell, and
H J Dobbs, and
G S Spathis, and
V R McCready, and
D O Cosgrove, and
C L Harmer
August 1985,
Journal of the Royal Society of Medicine,
C P Lowdell, and
H J Dobbs, and
G S Spathis, and
V R McCready, and
D O Cosgrove, and
C L Harmer
October 1977,
Annals of internal medicine,
C P Lowdell, and
H J Dobbs, and
G S Spathis, and
V R McCready, and
D O Cosgrove, and
C L Harmer
December 1984,
The New England journal of medicine,
C P Lowdell, and
H J Dobbs, and
G S Spathis, and
V R McCready, and
D O Cosgrove, and
C L Harmer
October 1983,
Hospital practice (Office ed.),
C P Lowdell, and
H J Dobbs, and
G S Spathis, and
V R McCready, and
D O Cosgrove, and
C L Harmer
August 1984,
The New England journal of medicine,
C P Lowdell, and
H J Dobbs, and
G S Spathis, and
V R McCready, and
D O Cosgrove, and
C L Harmer
February 1998,
Revista clinica espanola,
C P Lowdell, and
H J Dobbs, and
G S Spathis, and
V R McCready, and
D O Cosgrove, and
C L Harmer
October 2007,
Arquivos brasileiros de endocrinologia e metabologia,
C P Lowdell, and
H J Dobbs, and
G S Spathis, and
V R McCready, and
D O Cosgrove, and
C L Harmer
February 1990,
Journal of endocrinological investigation,
C P Lowdell, and
H J Dobbs, and
G S Spathis, and
V R McCready, and
D O Cosgrove, and
C L Harmer
May 1988,
Clinical endocrinology,
C P Lowdell, and
H J Dobbs, and
G S Spathis, and
V R McCready, and
D O Cosgrove, and
C L Harmer
January 1988,
European journal of nuclear medicine,
